RU2018109574A3 - - Google Patents

Download PDF

Info

Publication number
RU2018109574A3
RU2018109574A3 RU2018109574A RU2018109574A RU2018109574A3 RU 2018109574 A3 RU2018109574 A3 RU 2018109574A3 RU 2018109574 A RU2018109574 A RU 2018109574A RU 2018109574 A RU2018109574 A RU 2018109574A RU 2018109574 A3 RU2018109574 A3 RU 2018109574A3
Authority
RU
Russia
Application number
RU2018109574A
Other languages
Russian (ru)
Other versions
RU2018109574A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018109574A publication Critical patent/RU2018109574A/ru
Publication of RU2018109574A3 publication Critical patent/RU2018109574A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2018109574A 2015-08-20 2016-08-22 Применение хлорита для лечения болезней красных кровяных телец и опосредованных ими симптомов RU2018109574A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562207774P 2015-08-20 2015-08-20
US62/207,774 2015-08-20
PCT/IB2016/055011 WO2017029648A1 (en) 2015-08-20 2016-08-22 Use of chlorite to treat red blood cell diseases and indications mediated thereby

Publications (2)

Publication Number Publication Date
RU2018109574A RU2018109574A (ru) 2019-09-23
RU2018109574A3 true RU2018109574A3 (enExample) 2020-02-27

Family

ID=56896735

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018109574A RU2018109574A (ru) 2015-08-20 2016-08-22 Применение хлорита для лечения болезней красных кровяных телец и опосредованных ими симптомов

Country Status (6)

Country Link
US (1) US11813234B2 (enExample)
EP (1) EP3337489B1 (enExample)
JP (2) JP6900596B2 (enExample)
CN (1) CN108135930A (enExample)
RU (1) RU2018109574A (enExample)
WO (1) WO2017029648A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112168841A (zh) * 2019-07-05 2021-01-05 卢序 一种增加人一氧化氮生物利用度的方法
CN112386606A (zh) * 2019-08-19 2021-02-23 卢序 一种有第二信使作用增加积极氧化压力的氧化剂的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU754928B2 (en) 1997-10-06 2002-11-28 Oxo Chemie Ag Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
US20040224306A1 (en) 1999-11-30 2004-11-11 Frederich-Wilhelm Kuhne Evaluating and predicting clinical outcomes by gene expression analysis
EP1558237A4 (en) * 2002-09-27 2007-01-17 Martek Biosciences Corp IMPROVED BLOOD SUGAR CONTROL F RPRU-DIABETES AND / OR DIABETES TYPE II USING DOCOSAHEXAENSURE
EP2081021A4 (en) * 2006-10-16 2014-07-23 Sekisui Chemical Co Ltd HEMOGLOBIN DETERMINATION PROCESS
WO2008145376A1 (en) 2007-06-01 2008-12-04 Dimethaid Ag Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
US20140287064A1 (en) * 2009-04-28 2014-09-25 Karen G. Swenholt Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument
EA201290041A1 (ru) 2009-08-06 2012-07-30 Ньюралтус Фармасьютикалс, Инк. Лечение расстройств, связанных с макрофагами
US20110118180A1 (en) * 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Method of treatment of diabetes type 2 comprising add-on therapy to metformin
RU2014130080A (ru) 2011-12-22 2016-02-10 Нуво Рисерч Гмбх Липосомальные композиции хлоритов или хлоратов
CN104519890A (zh) * 2012-01-19 2015-04-15 Ibt美国公司 四氯十氧(tcdo)的治疗应用
US8748744B2 (en) * 2012-06-28 2014-06-10 Hubbell Incorporated Electrical box extender assembly
CA2945179A1 (en) * 2014-05-16 2015-11-19 Michael S. Mcgrath Methods and compositions for treatment of macrophage-related disorders

Also Published As

Publication number Publication date
JP2021130664A (ja) 2021-09-09
CA2995659A1 (en) 2017-02-23
RU2018109574A (ru) 2019-09-23
JP2018523711A (ja) 2018-08-23
US11813234B2 (en) 2023-11-14
JP6900596B2 (ja) 2021-07-07
US20180243334A1 (en) 2018-08-30
EP3337489A1 (en) 2018-06-27
WO2017029648A1 (en) 2017-02-23
BR112018003227A2 (pt) 2018-09-25
CN108135930A (zh) 2018-06-08
EP3337489B1 (en) 2023-01-18

Similar Documents

Publication Publication Date Title
BR112018005042A2 (enExample)
BR112017026097A2 (enExample)
CN303074392S (zh) 灶具（60g40me090-sft）
CN303072223S (zh) 雪茄烟缸(小情人迷你)
CN303066607S (zh) 电缆挂钩（a）
CN303068833S (zh) 用于机动车的格栅
CN303072191S (zh) 车灯（20）
CN303068776S (zh) 车辆前保险杠罩
CN303068225S (zh) 龙舟（国标22人）
CN303071237S (zh) 自动进样机构(36孔盘)
CN303072266S (zh) 按摩器（key035）
CN303068749S (zh) 汽车后悬液压锁
BE2015C047I2 (enExample)
BE2015C044I2 (enExample)
BR0007487B1 (enExample)
BR0007747B1 (enExample)
BR0000763F1 (enExample)
BR0002874B1 (enExample)
BR0007834B1 (enExample)
BR0008874B1 (enExample)
BR0006634B1 (enExample)
BR0009942B1 (enExample)
BR0003686B1 (enExample)
BR0002435B1 (enExample)
BR0107597B1 (enExample)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20210413